Macrosialin (CD68) Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-Macrosialin (CD68) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Macrosialin (CD68) |
| Clone | monoclonal |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2b |
| Format | fluorescein (FITC) conjugate |
| Size | 100 µg, |
| Concentration | 0.1 mg/ml |
| Applications | FCM |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Cluster of Differentiation 68 (CD68) antibody (FITC) is a Mouse monoclonal antibody against Cluster of Differentiation 68 (CD68). |
| Immunogen | n/a |
| Other Names | CD68, CD68 Molecule, CD68 Antigen, Scavenger Receptor Class D, Member 1, Macrophage Antigen CD68, GP110, Macrosialin, SCARD1, LAMP4, CD68, CD68, CD68 , CD68 , CD68 Molecule, CD68 Molecule, CD68 Molecule , CD68 Molecule , CD68 Antigen, CD68 Antigen, CD68 Antigen , CD68 Antigen , Scavenger Receptor Class D, Member 1, Scavenger Receptor Class D, Member 1, Scavenger Receptor Class D, Member 1 , Scavenger Receptor Class D, Member 1 , Macrophage Antigen CD68, Macrophage Antigen CD68, Macrophage Antigen CD68 , Macrophage Antigen CD68 , GP110, GP110, GP110 , GP110 , Macrosialin, Macrosialin, Macrosialin , Macrosialin , SCARD1, SCARD1, SCARD1 , SCARD1 , LAMP4, LAMP4, LAMP4 , LAMP4 |
| Gene, Accession # | CD68, UniProt: P34810 |
| Catalog # | abx415320 |
| Price | please inquire |
| Order / More Info | Macrosialin (CD68) Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies